newsfilter
← Latest News
Business Wire·

PepGen Announces Proposed $125.0 Million Public Offering of Common Stock

PEPG
  • PepGen Inc. (Nasdaq: PEPG) announced a public offering of $125.0 million in common stock & pre-funded warrants.
  • Underwriters have a 30-day option to purchase up to an additional $18.75 million of common stock.
  • Joint bookrunning managers for the offering are Leerink Partners, Stifel, & Guggenheim Securities.
  • Net proceeds will fund ongoing clinical development, working capital, & other general corporate purposes.
  • The offering is conducted under an effective Form S-3 shelf registration statement filed with the SEC on May 18, 2026.
  • PepGen is advancing PGN-EDODM1, a clinical candidate for myotonic dystrophy type 1, using its Enhanced Delivery Oligonucleotide (EDO) technology.
  • The press release includes forward-looking statements regarding the offering's completion, timing, size, & use of proceeds.